A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119) Meeting Abstract


Authors: Choe, H.; Shah, N. N.; Chevallier, P.; Rubio, M. T.; Schroeder, M. A.; Hardy, N. M.; Stiff, P. J.; Solano, C.; Yakoub-Agha, I.; Gutman, J. A.; Rowley, S. D.; Mico, M. C.; Terruzzi, E.; Duarte, R. F.; Morariu-Zamfir, R.; Arbushites, M.; Ding, K.; Perales, M. A.
Abstract Title: A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119)
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607547204054
DOI: 10.1182/blood-2020-140747
PROVIDER: wos
Notes: Meeting Abstract: 50 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Miguel-Angel Perales
    914 Perales